Xiuwu Pan

2.3k total citations
72 papers, 1.1k citations indexed

About

Xiuwu Pan is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Xiuwu Pan has authored 72 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Molecular Biology, 41 papers in Pulmonary and Respiratory Medicine and 22 papers in Oncology. Recurrent topics in Xiuwu Pan's work include Renal cell carcinoma treatment (23 papers), Ferroptosis and cancer prognosis (19 papers) and Renal and related cancers (11 papers). Xiuwu Pan is often cited by papers focused on Renal cell carcinoma treatment (23 papers), Ferroptosis and cancer prognosis (19 papers) and Renal and related cancers (11 papers). Xiuwu Pan collaborates with scholars based in China, United States and Croatia. Xiuwu Pan's co-authors include Xingang Cui, Fajun Qu, Sishun Gan, Danfeng Xu, Chuanmin Chu, Hai Huang, Jianqing Ye, Hong Yi, Xingang Cui and Qiwei Yang and has published in prestigious journals such as Journal of Clinical Investigation, SHILAP Revista de lepidopterología and Biomaterials.

In The Last Decade

Xiuwu Pan

65 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiuwu Pan China 21 627 353 295 238 184 72 1.1k
Yun Che China 21 752 1.2× 304 0.9× 568 1.9× 349 1.5× 163 0.9× 43 1.2k
Anh N. Diep United States 12 422 0.7× 161 0.5× 293 1.0× 272 1.1× 269 1.5× 17 893
Tong Lu China 19 716 1.1× 259 0.7× 523 1.8× 181 0.8× 70 0.4× 67 1.1k
Hanli Fan United States 12 318 0.5× 320 0.9× 243 0.8× 195 0.8× 210 1.1× 16 931
Denisa Dragu Romania 12 439 0.7× 197 0.6× 283 1.0× 289 1.2× 94 0.5× 20 850
Guoqing Ru China 17 463 0.7× 232 0.7× 262 0.9× 272 1.1× 92 0.5× 70 941
Leilei Liang China 20 832 1.3× 177 0.5× 559 1.9× 201 0.8× 191 1.0× 41 1.1k
Hongyun Xing China 20 685 1.1× 250 0.7× 439 1.5× 248 1.0× 78 0.4× 65 1.2k
Le Qu China 20 884 1.4× 415 1.2× 644 2.2× 234 1.0× 107 0.6× 61 1.4k
Chelsea Mayoh Australia 19 549 0.9× 248 0.7× 286 1.0× 267 1.1× 105 0.6× 59 1.1k

Countries citing papers authored by Xiuwu Pan

Since Specialization
Citations

This map shows the geographic impact of Xiuwu Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiuwu Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiuwu Pan more than expected).

Fields of papers citing papers by Xiuwu Pan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiuwu Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiuwu Pan. The network helps show where Xiuwu Pan may publish in the future.

Co-authorship network of co-authors of Xiuwu Pan

This figure shows the co-authorship network connecting the top 25 collaborators of Xiuwu Pan. A scholar is included among the top collaborators of Xiuwu Pan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiuwu Pan. Xiuwu Pan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Yifan, J Cui, Jiangui Liu, et al.. (2025). The comprehensive potential of AQP1 as a tumor biomarker: evidence from kidney neoplasm cohorts, cell experiments and pan-cancer analysis. Human Genomics. 19(1). 15–15. 2 indexed citations
2.
Cheng, Rui, Ye Wang, Xiuwu Pan, et al.. (2025). Application of Ultra Micro Angiography in Differential Diagnosis of Renal Tumors. Journal of Ultrasound in Medicine.
3.
Chu, Chuanmin, Bing-Nan Lu, Muchen Li, et al.. (2025). Bioinformatic analysis and retrospective clinical study identifying DNAJB4 as a pan-cancer biomarker with a highlight on kidney cancer. Clinical and Experimental Medicine. 25(1). 260–260.
4.
Chen, Wenjin, Wei Yang, Xiangmin Zhang, et al.. (2024). DEPDC1 as a metabolic target regulates glycolysis in renal cell carcinoma through AKT/mTOR/HIF1α pathway. Cell Death and Disease. 15(7). 533–533. 10 indexed citations
6.
Chen, Jiaxin, Wenbin Guan, Yijun Tian, et al.. (2024). Novel model of pyroptosis-related molecular signatures for prognosis prediction of clear cell renal cell carcinoma patients. International Journal of Medical Sciences. 21(3). 496–507. 4 indexed citations
7.
Hu, Zhilin, Xiaoyan Yu, Rui Ding, et al.. (2023). Glycolysis drives STING signaling to facilitate dendritic cell antitumor function. Journal of Clinical Investigation. 133(7). 58 indexed citations
9.
Li, Peng, Wu Qu, Xiuwu Pan, et al.. (2022). Nitrogen-doped graphene oxide with enhanced bioelectricity generation from microbial fuel cells for marine sewage treatment. Journal of Cleaner Production. 376. 134071–134071. 27 indexed citations
10.
Chen, Wenjin, Hao Cao, Jianwei Cao, et al.. (2022). Heterogeneity of tumor microenvironment is associated with clinical prognosis of non-clear cell renal cell carcinoma: a single-cell genomics study. Cell Death and Disease. 13(1). 50–50. 14 indexed citations
11.
Pan, Xiuwu, Da Xu, Wenjin Chen, et al.. (2021). USP39 promotes malignant proliferation and angiogenesis of renal cell carcinoma by inhibiting VEGF-A165b alternative splicing via regulating SRSF1 and SRPK1. Cancer Cell International. 21(1). 486–486. 18 indexed citations
12.
Ma, Juan, et al.. (2020). Effects of miR-330-3p on Invasion, Migration and EMT of Gastric Cancer Cells by Targeting PRRX1-Mediated Wnt/β-Catenin Signaling Pathway. SHILAP Revista de lepidopterología. 1 indexed citations
13.
Yang, Qiwei, Weiwei Chu, Wei Yang, et al.. (2020). Identification of RNA Transcript Makers Associated With Prognosis of Kidney Renal Clear Cell Carcinoma by a Competing Endogenous RNA Network Analysis. Frontiers in Genetics. 11. 540094–540094. 18 indexed citations
14.
Chen, Wenjin, Xiuwu Pan, & Xingang Cui. (2020). RCC Immune Microenvironment Subsequent to Targeted Therapy: A Friend or a Foe?. Frontiers in Oncology. 10. 573690–573690. 8 indexed citations
15.
Pan, Xiuwu, Lu Chen, Hong Yi, et al.. (2016). EIF3D silencing suppresses renal cell carcinoma tumorigenesis via inducing G2/M arrest through downregulation of Cyclin B1/CDK1 signaling. International Journal of Oncology. 48(6). 2580–2590. 39 indexed citations
17.
Xu, Danfeng, Yi Huang, Hai Huang, et al.. (2015). The prognostic value of lymphovascular invasion in radical prostatectomy: a systematic review and meta-analysis. Asian Journal of Andrology. 18(5). 780–780. 25 indexed citations
18.
Pan, Xiuwu, Lin Li, Yi Huang, et al.. (2015). Icaritin acts synergistically with epirubicin to suppress bladder cancer growth through inhibition of autophagy. Oncology Reports. 35(1). 334–342. 32 indexed citations
19.
Gao, Yi, Jingfei Teng, Hong Yi, et al.. (2015). The oncogenic role of EIF3D is associated with increased cell cycle progression and motility in prostate cancer. Medical Oncology. 32(7). 518–518. 24 indexed citations
20.
Zhang, Xiangmin, Dongxu Zhang, Fajun Qu, et al.. (2014). Knockdown of NOB1 expression inhibits the malignant transformation of human prostate cancer cells. Molecular and Cellular Biochemistry. 396(1-2). 1–8. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026